Zymeworks (ZYME) Earnings Date & Reports

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ZYME is expected to report earnings to fall 488.71% to $2.41 per share on November 10

Q3'26

Est.

$2.41

Q2'26

Missed

by $0.25

Q1'26

Missed

by $0.16

Q4'25

Missed

by $0.07

Q3'25

Beat

by $0.20

The last earnings report on August 06 showed earnings per share of -62 cents, missing the estimate of -37 cents. With 287.04K shares outstanding, the current market capitalization sits at 1.88B.

View a ticker or compare two or three

ZYME

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ZYME